TAYSHA GENE THERAPIES INC (TSHA) Institutional Ownership

TSHA is currently held by 2 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $3.28M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $1.85M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's TSHA position is now estimated to be worth approximately $2.56M, representing an estimated gain of +38.48% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, Polen Capital Management, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward TAYSHA GENE THERAPIES INC (TSHA).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20262$3,276,291732,951
Q4 20252$1,802,273327,686
Q2 20251$126,81954,900
Q4 20241$1,519,715878,448
Q2 20241$92,06441,100
Q1 20241$943328,500
Q4 20231$1,9421,097,400
Q3 20231$1,890598,000
Q2 20231$148224,400
Q1 20231$199249,600
Q4 20221$1,175519,800
Q3 20221$808418,500